Throat Lozenges Market is Auspiciously Holding to Dominate at a Sturdy CAGR of 4.20% During Forecast 2018-2023


Market Overview:

Throat-lozenges are the most preferred go-to solution for sore throat. Not only are the easily accessible but also cost-effective, which makes them the preferred choice of medication among patients. The global Throat Lozenges Market Analysis is anticipated to reach USD 6588.72 Mn at a CAGR of 4.20% over the forecast period of 2018-2023.

The global Throat Lozenges Market is driven by the towering prevalence of common cold and flu across the globe. Common cough and cold tend to occur all year round and are contagious in nature due to which they keep on spreading. Due to the inherent trend of resorting to over-the-counter medications, throat lozenges are predominantly the first line of treatment in case of throat infections. These lozenges are available in different flavors, and new flavors are being introduced continually, which has increased adoption among consumers. In addition, throat lozenges can be purchased and consumed without a prescription due to which they can be commercialized faster. Throat lozenges have evolved to become more effective in the past few years. Other factors supporting the growth of the market include the development of new ingredients and rapid product penetration in emerging economies.

Key players are focusing on the introduction of more effective formulas for capitalizing on the thriving demand. Flavor innovation is one of the major factors responsible for the proliferation of the throat lozenges market over the next couple of years. On the flip side, the increasing popularity of alternatives such as cough syrups, throat sprays, and antiseptic gargling solutions are poised to undermine the expansion of the throat lozenges market in the forthcoming years.
Competitive Landscape:
·         Bausch Health Companies Inc
·         Ricola AG
·         Prestige Brands Inc
·         Gepach International
·         Ernest Jackson
·         Procter & Gamble
·         Thornton & Ross
·         Doetsch Grether AG
·         Bliss GVS Pharma Ltd
·         Reckitt Benckiser Group plc
·         Wrigley Company
Segmentation:
·         The throat lozenges market has been segmented based on type, ingredient, and indication.
·         By type, the throat lozenges market has been segmented into hard candy lozenges, soft lozenges, and compressed lozenges. The hard lozenges segment has been further segmented into center filled hard candy lozenges, and chewy or caramel based medicated tablets.
·         By ingredient, the throat lozenges market has been segmented into menthol, eucalyptus oil, mint, peppermint oil, honey & ginger, lemon, and others. The menthol segment is the largest segment and is anticipated to reach USD 2084.62 Mn by the end of the forecast period.
·         By indication, the throat lozenges market has been segmented into cold & cough, sore throat, throat diseases, and others. The sore throat segment is leading the market while the cough & cold segment is likely to be the fastest-growing segment over the forecast period.
Regional Analysis:
Region-wise, the throat lozenges market size has been segmented into the Americas, the Middle East & Africa (MEA), Europe, and Asia Pacific (APAC).

The Americas market has been broadly categorized into South America and North America, where North America accounts for the majority share of 70%. High investment in healthcare and the presence of a broad base of aged population is aiding the growth of the market in the region. The Americas market is likely to expand at a CAGR of 3.72% over the forecast period.

Europe is the second-largest throat lozenges market and follows a similar growth pattern as the Americas'. High prevalence of the common cold in the region, along with increased healthcare spending is boosting the growth of the market.

The APAC throat lozenges market is anticipated to be the fastest-growing market over the forecast period. The presence of high geriatric as well as a pediatric population, who are more prone to cough and cold, is supporting the growth of the market. In addition, the prevalence trend of resorting to over-the-counter medications and preference for lozenges due to its cost-effectiveness has also been key to market growth. The APAC throat lozenges market is likely to expand at CAGR of 4.77% over the forecast period.




Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more